PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion
Background Despite the encouraging outcome of chimeric antigen receptor T cell (CAR-T) targeting B cell maturation antigen (BCMA) in managing relapsed or refractory multiple myeloma (RRMM) patients, the therapeutic side effects and dysfunctions of CAR-T cells have limited the efficacy and clinical a...
Saved in:
| Main Authors: | Lei Yu, Yan Wang, Jin Wang, Zhiqiang Liu, Feng Liu, Han Zhao, Yi Tao, Jian-Qing Mi, Nan Xu, Wanyan Ouyang, Shi-Wei Jin, Wei-Yang Liu, Liuqingqing Zhang, Liqing Kang, Yuanfang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-04-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/4/e008429.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TET2 downregulation enhances the antitumor efficacy of CD19 CAR T cells in a preclinical model
by: Yeongrin Kim, et al.
Published: (2025-02-01) -
Research on strategies to inhibit CAR-T cell exhaustion
by: FU Qiongyu, HAO Xinbao, TAO Shi
Published: (2025-04-01) -
Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
by: Xia Liu, et al.
Published: (2022-10-01) -
B and T lymphocyte attenuator (BTLA) and PD-1 pathway dual blockade promotes antitumor immune responses by reversing CD8+ T-cell exhaustion in non-small cell lung cancer
by: Yang Zhang, et al.
Published: (2025-05-01) -
Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy
by: Bolan Yu, et al.
Published: (2022-02-01)